AHRQ To Compare Treatments For Women With Coronary Artery Disease
This article was originally published in The Pink Sheet Daily
Agency for Healthcare Research and Quality seeks feedback on questions for a study of how women respond to various treatments, including medication and bypass surgery.
You may also be interested in...
The Agency for Healthcare Research and Quality is planning to spend $173 million, of the $300 million allocated to it for comparative effectiveness research by the American Recovery and Reinvestment Act, on evidence generation
Imaging stakeholders call for Medicare coverage of beta amyloid positron emission tomography scans to help diagnose and manage dementia patients, but clinical societies warn against using the technology as a screening tool for Alzheimer’s disease. CMS took comments through Nov. 8 on its ongoing national coverage analysis.
With a CE mark in hand, Exonhit is training its sights on the U.S. market. A 160-patient pilot study conducted through the Cleveland Clinic completed enrollment a few weeks ago.